Alltech: Sel-Plex® From Alltech Receives EFSA Green Light On Human Health Claims
11/02/2009 02:45PM
Bookmark
Subscribe
Global animal health and nutrition company Alltech, is pleased to announce that several human health claims relating to Sel-Plex® have been accepted by the European Food Safety Authority (EFSA).
The EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)2 has accepted health claims linking the dietary intake of Sel-Plex to “protection of DNA, proteins and lipids from oxidative damage, normal function of the immune system, normal thyroid function and normal spermatogenesis.”
Sel-Plex, from Alltech, is the only FDA reviewed form of organic selenium. This is the first strain specific form of organic selenium to be EU approved for all animal species (Strain: Saccharomyces cerevisiae CNCM I-3060). Selenium is an essential nutrient for both animals and people, and plays a critical role in metabolism, normal growth, reproductive health, and immunity. Because of its specific organic form, Sel-Plex is better absorbed and retained by the animal.
Marc Larousse, vice president, Alltech Europe, said “Alltech has been the sole leader in submitting extensive data and research petitioning EFSA for this successful opinion for Sel-Plex. This positive opinion by EFSA confirms the role that Sel-Plex plays in human nutrition. It further underlines the significance Sel-Plex has in the full food chain from the animal to the human. We are pleased with the acceptance from EFSA. Alltech is committed to its pioneering role utilizing nutrigenomics and gene expression profiling as an effective tool for improving nutritional strategies in both animals and humans.”